We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CTXR market cap is 20.79M. The company's latest EPS is USD -5.2006 and P/E is -0.52.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.13M | -9.34M | -10.97M | -10.63M | -11.05M |
| Net Income | -11.1M | -9.23M | -8.54M | -10.9M | -11.52M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.71M | -23.53M | -39.22M | -36.73M | -42M |
| Net Income | -17.55M | -23.05M | -39.54M | -33.69M | -40.19M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 103.61M | 97.4M | 90.71M | 97.09M | 116.65M |
| Total Liabilities | 12.18M | 12.07M | 10.74M | 10.81M | 42.55M |
| Total Equity | 91.43M | 85.34M | 79.97M | 86.28M | 74.1M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 43.77M | 142.43M | 114M | 103.61M | 116.65M |
| Total Liabilities | 10.1M | 9.65M | 10.57M | 12.18M | 42.55M |
| Total Equity | 33.67M | 132.78M | 103.43M | 91.43M | 74.1M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.06M | -6.14M | -13.92M | -22.29M | -28.2M |
| Investing | N/A | N/A | N/A | N/A | -5M |
| Financing | 13.83M | N/A | N/A | 13.72M | 9.97M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.93M | -24.25M | -28.36M | -29.06M | -28.2M |
| Investing | -2k | -40.01M | N/A | N/A | -5M |
| Financing | 22.9M | 120.47M | N/A | 13.83M | 9.97M |
| Market Cap | 20.79M |
| Price to Earnings Ratio | -0.52 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.42 |
| Price to Book Ratio | 0.28 |
| Dividend Yield | - |
| Shares Outstanding | 7.73M |
| Average Volume (1 week) | 116.59k |
| Average Volume (1 Month) | 112.27k |
| 52 Week Change | -82.87% |
| 52 Week High | 26.75 |
| 52 Week Low | 2.44 |
| Spread (Intraday) | 0.29 (9.73%) |
| Company Name | Citius Pharmaceuticals Inc |
| Address |
112 north curry street carson city, nevada 89703 |
| Website | https://www.citiuspharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
